Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsReceivables - NetShares Repurchased
Ratios

Tg Therapeutics (TGTX) Receivables - Other (2016 - 2024)

Tg Therapeutics (TGTX) has 5 years of Receivables - Other data on record, last reported at $23.5 million in Q4 2024.

  • For Q4 2024, Receivables - Other rose 298.31% year-over-year to $23.5 million; the TTM value through Dec 2024 reached $23.5 million, up 298.31%, while the annual FY2024 figure was $23.5 million, 298.31% up from the prior year.
  • Receivables - Other reached $23.5 million in Q4 2024 per TGTX's latest filing, up from $6.5 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $23.5 million in Q4 2024 and bottomed at $5.9 million in Q4 2023.